|
1
|
Mínguez C, García-Deltoro M, Flores J,
Galindo MJ, Montero M, Reus S, Carmena J, Masiá M, Amador C and
Ortega E: on the behalf of the COINFECOVA-2 study group:
Interferon-free therapy for treating hepatitis C virus in
difficult-to-treat HIV-coinfected patients. AIDS. 32:337–346.
2018.PubMed/NCBI
|
|
2
|
Collins LF, Chan A, Zheng J, Chow SC,
Wilder JM, Muir AJ and Naggie S: Direct-acting antivirals improve
access to care and cure for patients with HIV and chronic HCV
infection. Open Forum Infect Dis. 5:ofx2642017.PubMed/NCBI
|
|
3
|
Ahmadinejad Z, Abdiliaei Z, Mohamadi R and
Rezahosseini O: Treatment related hematologic changes in a
population of Iranian patients with chronic hepatitis C infection
from 2009 to 2014. Iran J Public Health. 46:1386–1394.
2017.PubMed/NCBI
|
|
4
|
Tavitian-Exley I, Maheu-Giroux M, Platt L,
Heimer R, Uusküla A, Levina O, Vickerman P and Boily MC:
Differences in risk behaviours and HIV status between primary
amphetamines and opioid injectors in Estonia and Russia. Int J Drug
Policy. 53:96–105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim YC, Ahn JY, Kim JM, Kim YJ, Park DW,
Yoon YK, Song JY, Kim SW, Lee JS, Choi BY, et al: Human
immunodeficiency virus (HIV) and hepatitis virus coinfection among
HIV-infected Korean patients: The Korea HIV/AIDS cohort study.
Infect Chemother. 49:268–274. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shmagel KV, Korolevskaya LB, Saidakova EV,
Shmagel NG, Chereshnev VA, Margolis L, Anthony D and Lederman M:
HCV coinfection of the HIV-infected patients with discordant
CD4+ T-cell response to antiretroviral therapy leads to
intense systemic inflammation. Dokl Biol Sci. 477:244–247. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suda G, Ogawa K, Morikawa K and Sakamoto
N: Treatment of hepatitis C in special populations. J
Gastroenterol. 53:591–605. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Charre C, Cotte L, Kramer R, Miailhes P,
Godinot M, Koffi J, Scholtès C and Ramière C: Hepatitis C virus
spread from HIV-positive to HIV-negative men who have sex with men.
PLoS One. 13:e01903402018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ramamurthy M, Sankar S, Kannangai R,
Nandagopal B and Sridharan G: Application of viromics: A new
approach to the understanding of viral infections in humans.
Virusdisease. 28:349–359. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Benhammou V, Tubiana R, Matheron S,
Sellier P, Mandelbrot L, Chenadec JL, Marel E, Khoshnood B and
Warszawski J: ANRS CO1/CO11-EPF French Perinatal Cohort study
group: HBV or HCV coinfection in HIV-1-infected pregnant women in
France: Prevalence and pregnancy outcomes. J Acquir Immune Defic
Syndr. 77:439–450. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mohsenizadeh M, Mollaei HR and Ghaziizadeh
M: Seroepidemiological study of hepatitis B, C and HIV among blood
donors in Kerman. Asian Pac J Cancer Prev. 18:3267–3272.
2017.PubMed/NCBI
|
|
12
|
Köse Ş, Ödemiş I, Çelik D, Tatar Gireniz
B, Akbulut I and Çiftdoğan DY: Hepatitis A, B, C and HIV
seroprevalence among Syrian refugee children admitted to outpatient
clinics. Infez Med. 25:339–343. 2017.PubMed/NCBI
|
|
13
|
Raj A, Mittal G and Bahadur H: Factors
affecting the serological testing of cadaveric donor cornea. Indian
J Ophthalmol. 66:61–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Husseinzadeh H, Chiasakul T, Gimotty PA,
Pukenas B, Wolf R, Kelty M, Chiang E, Fogarty PF and Cuker A:
Prevalence of and risk factors for cerebral microbleeds among adult
patients with haemophilia A or B. Haemophilia. 24:1271–277. 2018.
View Article : Google Scholar
|
|
15
|
Fard Najafi S, Schietroma I, Scheri Corano
G, Giustini N, Serafino S, Cavallari EN, Pinacchio C, De Girolamo
G, Ceccarelli G, Scagnolari C, et al: Direct-acting antiviral
therapy enhances total CD4+ and CD8+ T-cells
responses, but does not alter T-cells activation among HCV
mono-infected, and HCV/HIV-1 co-infected patients. Clin Res Hepatol
Gastroenterol. 401:302–362. 2017.
|
|
16
|
Sumbu BMM, Longo-Mbenza B, Ahuka-Mundeke
S, Muwonga JM, Mvumbi-Lelo G, Maphana HM, Kayembe Nzongola-Nkasu D
and Kalumbu FM: Association between the viruses of the acquired
immunodeficiency syndrome and the hepatitis C virus among young
blood donors in Kinshasa: Retrospective analysis of 10 years.
Transfus Clin Biol. 25:26–34. 2018.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Notari S, Tempestilli M, Fabbri G,
Libertone R, Antinori A, Ammassari A and Agrati C: UPLC-MS/MS
method for the simultaneous quantification of sofosbuvir,
sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of
HIV/HCV co-infected patients. J Chromatogr B Analyt Technol Biomed
Life Sci. 1073:183–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hua S, Vigano S, Tse S, Zhengyu O,
Harrington S, Negron J, Garcia-Broncano P, Marchetti G, Genebat M,
Leal M, et al: Pegylated IFN-α-induced NK cell activation is
associated with HIV-1 DNA decline in ART-treated HIV-1/HCV
co-infected patients. Clin Infect Dis. 20:93–96. 2017.
|
|
19
|
D'Aleo F, Ceccarelli M, Rullo Venanzi E,
Facciolà A, Di Rosa M, Pinzone MR, Condorelli F, Visalli G, Picerno
I, Berretta M, et al: Hepatitis C-related hepatocellular carcinoma:
Diagnostic and therapeutic management in HIV-patients. Eur Rev Med
Pharmacol Sci. 21:5859–5867. 2017.PubMed/NCBI
|
|
20
|
Rial-Crestelo D, Rodríguez-Cola M,
González-Gasca FJ, Geijo-Martínez P, Belinchón-Moya O,
Martínez-Alfaro E, Mateos-Rodríguez F, Barberá JR, Yzusqui M,
Casallo S, et al: Effectiveness of direct-acting antiviral therapy
in patients with a HCV/HIV coinfection. A multicenter cohort study.
Rev Esp Enferm Dig. 110:35–43. 2018.PubMed/NCBI
|
